Skip to main content
Tech.euFundingExplorerBeta

Smart Korea UTC Bio-Healthcare Venture Fund

Investor profile

Venture capital

Smart Korea UTC Bio-Healthcare Venture Fund has backed 1 European tech company across 1 funding round in 2021, joining rounds totalling €18M. Most active in Healthtech. Data as of 4 Nov 2026.

Deals
1
distinct rounds
Companies
1
backed
Active span
2021
1 yr
Total round €
€18M
sum of rounds joined

Deals by year

distinct rounds / year
Smart Korea UTC Bio-Healthcare Venture Fund — deals by year — interactive chart.
Data table
Smart Korea UTC Bio-Healthcare Venture Fund — deals by year
20211

Top sectors

by deals
Smart Korea UTC Bio-Healthcare Venture Fund — top sectors — interactive chart.
Data table
Smart Korea UTC Bio-Healthcare Venture Fund — top sectors
Healthtech1

Stages

by deals
Smart Korea UTC Bio-Healthcare Venture Fund — stages — interactive chart.
Data table
Smart Korea UTC Bio-Healthcare Venture Fund — stages
Series B1

Countries

by deals
Smart Korea UTC Bio-Healthcare Venture Fund — countries — interactive chart.
Data table
Smart Korea UTC Bio-Healthcare Venture Fund — countries
Belgium1

Co-investment network

shared rounds
Co-investment network — interactive chart.
Smart Korea UTC Bio-Healthcare Venture Fund — 1 dealsSmart Korea UTC Bio-Healthcare Venture FundAlpha Ventures — 1 shared deals · click to openAlpha VenturesBrain Asset Management — 1 shared deals · click to openBrain Asset ManagementHansongneotech Co. — 1 shared deals · click to openHansongneotech Co.Korea Investment Partners — 1 shared deals · click to openKorea Investment PartnersNoshaq — 1 shared deals · click to openNoshaqSambrinvest — 1 shared deals · click to openSambrinvestSFPI-FPIM — 1 shared deals · click to openSFPI-FPIMSRIW — 1 shared deals · click to openSRIW

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
PDC*line PharmaBelgium1€18M

Biggest deals

top 10 by amount
CompanyStageAmountDate
PDC*line PharmaSeries B€18M2021-12
← Back to investors